Pharmafile Logo
Pharmafocus logo
Advanced Search

C diff

Showing 6 posts of 6 posts found.

clostridium_difficile_cdc

Researchers explain link between anti-inflammatories and C. difficile

January 9, 2019
Research and Development C diff, C.Diff, Vanderbilt, anti-inflammatory, cdi, nsaids, research

In the past, observational studies have found a link between the use of common nonsteroidal anti-inflammatory drugs (NSAIDs) and increased …

News
virus-1812092_960_720

Rebiotix delivers a gut bug PUNCH in C. diff trial

April 13, 2017
Research and Development C diff, C. diff, Rebiotix, microbiome

Rebiotix is one a new breed of companies that aims to use the human body’s microbiome to treat illnesses and …

News
merckwindow

MSD faces delay in C. diff drug approval as FDA requests more data

July 22, 2016
Medical Communications, Research and Development C diff, FDA, MSD, Merck

MSD, known as Merck in the US and Canada, has received a setback in its bid to get new C. …

News
sanofi pasteur image

Sanofi starts C. diff study

October 28, 2013
Research and Development, Sales and Marketing C diff, Sanofi Pasteur, cdi, clostridium

Sanofi’s vaccines division is beginning a Phase III programme looking at the safety and effectiveness of an investigational treatment for …

News

Sanofi’s C diff vaccine fast tracked by FDA

November 10, 2010
Research and Development C diff, C diff vaccine, C difficile, Clostridium difficile, FDA, FDA fast-track, Sanofi, Sanofi Pasteur

A new vaccine aimed at preventing C difficile infections has been fast tracked by the FDA. The regulator’s decision signals …

News

Government funds superbug nurses in every hospital

January 9, 2008
C diff, NHS

 Millions of pounds in extra funding is to be given to hospitals in England to appoint a team of nurses …

News

Latest content

Prism BioLab and Ono Pharmaceutical enter joint research and licensing agreement

April 25, 2024

Ascendis Pharma’s Yorvipath approved by MHRA for hypoparathyroidism treatment

April 25, 2024

Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals

April 24, 2024

GSK’s Jemperli accepted for FDA review for endometrial cancer treatment

April 24, 2024

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024